Time to Symptom Resolution After Total Thyroidectomy for Graves' Disease
- PMID: 36179596
- PMCID: PMC10496743
- DOI: 10.1016/j.jss.2022.07.027
Time to Symptom Resolution After Total Thyroidectomy for Graves' Disease
Abstract
Introduction: Total thyroidectomy (TT) has been shown to be a safe and effective treatment for Graves' disease. However, the time course for improvement of symptoms has not been defined.
Methods: With an institutional review board approval, we prospectively gathered survey data of all patients (n = 79) undergoing TT for Graves' disease at a single institution from 2019 to 2021. After informed consent was obtained, patients completed surveys preoperatively and at 2 wk followed by monthly postoperative visits/phone calls. Patient demographics and survey results were collected and analyzed. Symptom recovery time was evaluated using Kaplan-Meier analysis.
Results: A total of 50 patients completed the survey on postoperative follow-up (response rate 63%). Average age was 38 y (range 12-80 y) and 88% of patients were female. The most common preoperative symptoms were fatigue (90%) and heat/cold intolerance (88%). Tremor (median time to resolution: 1 wk; interquartile range [IQR] 1-3), diarrhea (median 1 wk [IQR 1-3]), and palpitations (median 1 wk [IQR 1-3]) resolved the most rapidly followed by eye symptoms (median 3 wk [IQR 1-6]), heat/cold intolerance (median 3 wk [IQR 3-30]), memory deficits (median 3 wk [IQR 1-undefined]), and fatigue (median: 3 wk [IQR 1-14]). There were no significant differences in time to resolution of symptoms by gender or age (less than versus 40 y and older). Those with uncontrolled Graves' had more severe symptoms but no difference in time to resolution from the euthyroid Graves' patients.
Conclusions: Many Graves' disease symptoms improve rapidly following TT, with a median time to improvement of less than 1 mo.
Keywords: Endocrine surgery; Graves' disease; Hyperthyroidism; Patient centered care; Symptom relief; Total thyroidectomy.
Copyright © 2022 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Patient-Reported Outcomes Following Total Thyroidectomy for Graves' Disease.Thyroid. 2022 Jan;32(1):54-64. doi: 10.1089/thy.2021.0285. Epub 2021 Dec 3. Thyroid. 2022. PMID: 34663089 Free PMC article.
-
Total thyroidectomy is superior to subtotal thyroidectomy for management of Graves' disease in the United States.World J Surg. 2010 Jun;34(6):1261-4. doi: 10.1007/s00268-009-0337-3. World J Surg. 2010. PMID: 20033406
-
Randomized clinical trial of bilateral subtotal thyroidectomy versus total thyroidectomy for Graves' disease with a 5-year follow-up.Br J Surg. 2012 Apr;99(4):515-22. doi: 10.1002/bjs.8660. Epub 2012 Jan 27. Br J Surg. 2012. PMID: 22287122 Clinical Trial.
-
Treatment of patients with Graves' disease and the appropriate extent of thyroidectomy.Best Pract Res Clin Endocrinol Metab. 2019 Aug;33(4):101319. doi: 10.1016/j.beem.2019.101319. Epub 2019 Aug 31. Best Pract Res Clin Endocrinol Metab. 2019. PMID: 31530446 Review.
-
Graves' disease in children.Ann Endocrinol (Paris). 2018 Dec;79(6):647-655. doi: 10.1016/j.ando.2018.08.001. Epub 2018 Aug 16. Ann Endocrinol (Paris). 2018. PMID: 30180972 Review.
Cited by
-
From routine to rescue: Thyroidectomy for life-threatening thyrotoxicosis.World J Surg. 2024 Dec;48(12):2892-2898. doi: 10.1002/wjs.12312. Epub 2024 Aug 12. World J Surg. 2024. PMID: 39134403
References
-
- McLeod DS, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine. 2012;42:252–265. - PubMed
-
- Weetman AP. Graves’ disease. N Engl J Med. 2000;343:1236–1248. - PubMed
-
- Cohen O, Ronen O, Khafif A, et al. Revisiting the role of surgery in the treatment of Graves’ disease. Clin Endocrinol (Oxf). 2021;96:747–757. - PubMed
-
- In H, Pearce EN, Wong AK, et al. Treatment options for Graves disease: a cost-effectiveness analysis. J Am Coll Surg. 2009;209:170–179. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources